arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

OmniAb, Inc.

OABI
$3.06 ▲ +0.79 (+35.10%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
7 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

OmniAb, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $347.7M
Dividend Yield
Revenue Growth -29.3%
Op. Margin -369.5%
ROIC -25.2%
FCF / Share $-0.33
Trailing P/E
Price / Book 1.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$18.67M
↓ -29.3%
Net Income Profit after all expenses
$-64.78M
↓ -4.4%
Operating Margin Operating profit as % of sales
-369.5%
↓ -30.9% 0th
FCF / Share Free cash flow per share
$-0.33
↑ +19.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
26
Cash Quality
43

Dividend History

Dividend / share · sourced from SEC filings
$2.50 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters